Showing 521-530 of 7020 results for "".
Journal Club: Oral JAK Inhibitors in Moderate-to-Severe AD
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-oral-jak-inhibitors-moderate-severe-ad/24539/Peter Lio, MD, talks with Robert Sidbury, MD, MPH, a dermatologist at Seattle Children's Hospital, about nuanced differences in guideline-recommended use of oral JAK inhibitors in pediatric patients with moderate-to-severe atopic dermatitis (AD) provided in the Annals of Allergy, Asthma, and ImmunolASLMS 2024 Meeting Wrap-Up
https://practicaldermatology.com/topics/news/aslms-2024-meeting-wrapup/24462/The American Society for Laser Medicine and Surgery (ASLMS) recently wrapped its 43rd Annual Conference on Energy-based Medicine and Science in Baltimore (ASLMS 2024), where leading practitioners and researchers gathered to share groundbreaking advancements and insights in the field of laser medicinUnlocking the Potential of Regenerative Medicine in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/unlocking-the-potential-of-regenerative-medicine-in-dermatology/24022/Advances in regenerative medicine have led to a new generation of therapeutic approaches and options.How Exceptional Reception Design Can Maximize Sales
https://practicaldermatology.com/topics/practice-management/how-exceptional-reception-design-can-maximize-sales/23779/Many factors determine the impact of this generally small but important space.An Updated, Holistic Approach to Managing Hyperpigmentation
https://practicaldermatology.com/topics/pigmentary-disorders/an-updated-holistic-approach-to-managing-hyperpigmentation/20102/As an early adopter of Cyspera, Suneel Chilukuri, MD has witnessed the evolution of the topical formulation. Cyspera Intensive System provides a three-step holistic approach to skincare that supports healthier, brighter skin within about four to six weeks.DermWireTV: Skyrizi for PsA; Toxins and Wound Healing at Maui Derm; SDDS Registration
https://practicaldermatology.com/topics/psoriasis/skyrizi-for-psa-toxins-and-wound-healing-at-maui-derm-sdds-registration-dermwiretv/20057/Skyrizi (AbbVie) is now approved for the treatment of adults with active psoriatic arthritis. Michael Gold, MD was among the speakers who offered updates on cosmetic trends as well as medical care at Maui Dermatology for Dermatologists last week. He spoke about high-dose neurotoxins. Robert KirsnerEmail Marketing: Why and How To Use It For Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/email-marketing-why-and-how-to-use-it-for-your-dermatology-practice/23641/Text and social media have not displaced traditional email marketing strategies.How Artificial Intelligence and Chatbots are Enhancing Medical Experiences for Patients
https://practicaldermatology.com/topics/practice-management/how-artificial-intelligence-and-chatbots-are-enhancing-medical-experiences-for-patients/23570/Medical practices are leveraging technology to increase patient care and overall efficiencies to improve the all-around customer experience.How Physicians Are Unlike Most US Investors
https://practicaldermatology.com/topics/practice-management/how-physicians-are-unlike-most-us-investors/23370/A look at how the difference in the tax situations of physicians and average retail investors, and why these differences matter.Buyer Beware: CBD Products May Peddle False Hope Amid Corona Fears
https://practicaldermatology.com/series/dermatology-dispatches/buyer-beware-cbd-products-may-peddle-false-hope-amid-corona-fears/19775/Any claims that a medical cannabinoid-based product can kill COVID-19 are “absolutely unsubstantiated,” warns Adam Friedman, MD. There is no evidence that these products contain any antiviral properties, and patients should be advised against believing such claims.